Health
India Drug Regulators Halt Sun Pharma Eye-Care Production at Assam Facility
Indian regulators ordered a halt to ophthalmic-product manufacturing at a Sun Pharma facility after reported quality-system failures.
Indian regulators ordered a halt to ophthalmic-product manufacturing at a Sun Pharma facility after reported quality-system failures.